DA

DaVita

DVA
NYSEHealth Care
$208.66
USD
+4.83(+2.37%)
At close: Jun 12, 20:00 UTC

Open

$208.84

Prev. Close

$209.13

High

$209.08

Low

$208.21

Market Snapshot

Market Cap

$13.94B

P/E Ratio

17.8

EPS

11.01

Revenue

$12.82B

About

DaVita, Inc. engages in the provision of medical care services. The company is headquartered in Denver, Colorado and currently employs 78,000 full-time employees. The firm is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. The company also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

Recently from Cashu